Predictive biomarkers of response to immune checkpoint inhibitors

by María Sacramento Díaz-Carrasco, Eva González-Haba, Juana Inés García-Soler, Alberto Espuny-Miró
Published 2020-07-01

A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein

by Eva González-Haba-Peña, Silvia Manrique-Rodríguez, Ana María Herranz-Alonso, Irene Iglesias-Peinado, María Sanjurjo-Sáez
Published 2018-11-01

Causes of the emergency department visits in cancer patients: postchemotherapy toxicity

by Silvia Buendía-Bravo, Eva González-Haba Peña, Raquel García-Sánchez, Paula Arrabal-Durán, María Norberta Sánchez-Fresneda, María Sanjurjo-Sáez
Published 2015-11-01

Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients

by Eva González-Haba-Peña, Margarita Garrido-Siles, María Jose Martínez-Bautista, Amparo Burgos-San José, Azucena Aldaz-Pastor, Irene Mangues-Bafalluy
Published 2020-09-01

Comparative study of preparation of hazardous drugs with different closed-system drug transfer devices by means of simulation with fluorescein

by Eva González-Haba Peña, Silvia Manrique Rodríguez, Ana Mª Herranz Alonso, Patricia Pérez Castán, Mónica Moreno Gálvez, Irene Iglesias Peinado, María Sanjurjo Saez
Published 2016-12-01

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Phar...

by Silvia Valero-García, Eva González-Haba, Maria Queralt Gorgas-Torner, José María Alonso-Herreros, Ana Cristina Cercós Lletí, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernandez, Olga Delgado-Sánchez
Published 2021-03-01

Off-label use of oncology drugs: national survey results

by Eva González-Haba Peña, María José Agustín Ferrández, Irene Mangues Bafalluy, Nicolás Alfredo López, María Dolores Fraga Fuentes, Roberto Marín Gil, María José Martínez Bautista, María José Martínez Bautista, María José Martínez Bautista, Ana Clopés Estela
Published 2015-09-01

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

by Miguel Martin, Rocio Ramos-Medina, Rebeca Bernat, Jose Angel García-Saenz, Maria del Monte-Millan, Enrique Alvarez, Maria Cebollero, Fernando Moreno, Eva Gonzalez-Haba, Oscar Bueno, Paula Romero, Tatiana Massarrah, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Ricardo Gonzalez del Val, Nerea Lobato, Patricia Rincon, Maria Isabel Palomero, Ivan Marquez-Rodas, Santiago Lizarraga, Fernando Asensio, Sara Lopez-Tarruella
Published 2021-03-01